Literature DB >> 11090022

Results of liver transplantation for nodular regenerative hyperplasia.

J S Radomski1, K A Chojnacki, M J Moritz, R Rubin, V T Armenti, G A Wilson, S Herrine, M Conn.   

Abstract

Liver transplantation has been performed in individuals with a pretransplant clinical diagnosis of cirrhosis but with nodular regenerative hyperplasia histologically. The purpose of this report is to investigate the results of liver transplantation in patients proven to have nodular regenerative hyperplasia post-transplant. A retrospective review was undertaken of four patients who underwent liver transplantation with a histologic diagnosis of nodular regenerative hyperplasia. All were felt to be cirrhotic on clinical grounds. Final histology of the explanted liver was confirmed by a single pathologist. Their ages ranged from 39 to 54 years, and three of the four were male. Three had pretransplant needle liver biopsies, two percutaneous and one transjugular. All revealed nonspecific reactive changes. Ultrasound and MRI were interpreted as consistent with cirrhosis in four of four and three of four cases, respectively. Portal vein flow was hepatopedal in three and absent in one. Pretransplant clinical characteristics and frequency were as follows: bleeding varices two, clinical ascites three, encephalopathy three, and impaired hepatic synthetic function two. All four patients underwent successful liver transplantation. There were no episodes of acute rejection. All are alive and well with normal graft function 2 to 4 years post-transplant. We conclude the following. 1) Patients with clinical end-stage liver disease due to underlying nodular regenerative hyperplasia can successfully undergo transplantation. 2) Nodular regenerative hyperplasia can present with signs and symptoms of liver failure, is difficult to diagnose by needle biopsy, and can be difficult to discriminate clinically from cirrhosis. 3) Although each case must be individually evaluated transplantation may be the optimal therapy in patients presenting with complications of liver failure.

Entities:  

Mesh:

Year:  2000        PMID: 11090022

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  9 in total

1.  Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation.

Authors:  Sunil Taneja; Yogesh Chawla; Radha K Dhiman
Journal:  Hepatol Int       Date:  2011-09-03       Impact factor: 6.047

2.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Authors:  G Vernier-Massouille; J Cosnes; M Lemann; P Marteau; W Reinisch; D Laharie; G Cadiot; Y Bouhnik; M De Vos; A Boureille; B Duclos; P Seksik; J-Y Mary; J-F Colombel
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

Review 3.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients.

Authors:  Sanjiv Saigal; Nabeen C Nayak; Deepali Jain; Vinay Kumaran; Ravi Mohanka; Neeraj Saraf; Amit Rastogi; Naimesh Mehta; Samiran Nundy; Arvinder Soin
Journal:  Hepatol Int       Date:  2011-01-12       Impact factor: 6.047

Review 5.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

6.  Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

Authors:  Berrie Meijer; Melek Simsek; Hans Blokzijl; Robert A de Man; Minneke J Coenraad; Gerard Dijkstra; Carin Mj van Nieuwkerk; Chris Jj Mulder; Nanne Kh de Boer
Journal:  United European Gastroenterol J       Date:  2016-11-16       Impact factor: 4.623

7.  Acute deterioration of idiopathic portal hypertension requiring living donor liver transplantation: a case report.

Authors:  Takamitsu Inokuma; Susumu Eguchi; Tetsuo Tomonaga; Kensuke Miyazaki; Koji Hamasaki; Hirotaka Tokai; Masaaki Hidaka; Kosho Yamanouchi; Mitsuhisa Takatsuki; Sadayuki Okudaira; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

Review 8.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

Review 9.  Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.

Authors:  Shigeyuki Kawachi; Naokazu Chiba; Masashi Nakagawa; Toshimichi Kobayashi; Kosuke Hikita; Toru Sano; Koichi Tomita; Hiroshi Hirano; Yuta Abe; Hideaki Obara; Motohide Shimazu
Journal:  BMC Surg       Date:  2020-10-29       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.